A detailed history of Atomi Financial Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 6,081 shares of GILD stock, worth $595,329. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,081
Previous 4,471 36.01%
Holding current value
$595,329
Previous $307 Million 66.19%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$66.59 - $83.99 $107,209 - $135,223
1,610 Added 36.01%
6,081 $510 Million
Q2 2024

Jul 26, 2024

SELL
$63.15 - $72.88 $51,088 - $58,959
-809 Reduced 15.32%
4,471 $307 Million
Q1 2024

May 07, 2024

SELL
$71.58 - $87.29 $35,646 - $43,470
-498 Reduced 8.62%
5,280 $387 Million
Q4 2023

Feb 08, 2024

BUY
$73.27 - $83.09 $423,354 - $480,094
5,778 New
5,778 $468 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $123B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Atomi Financial Group, Inc. Portfolio

Follow Atomi Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atomi Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atomi Financial Group, Inc. with notifications on news.